Table 1
| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) | 1 | Y | 1 Tissue for PD-L1 testing | 1000 | 635 | 342 | 186 | 87 | 31 | 12 | 01/18/2017 | 406 | 196 |
| 635 | 342 | 186 | 87 | 31 | 12 | |||||||||
| 2 | Y | 2 Observation | 1000 | 272 | 147 | 81 | 37 | 14 | 3 | 01/18/2017 | ||||
| 3 MK-3475 (Pembrolizumab) | 267 | 146 | 83 | 39 | 11 | 2 | ||||||||
| 539 | 293 | 164 | 76 | 25 | 5 | |||||||||
| S1706-Breast, Inflammatory, RT +/- Olaparib | 1 | Y | 1 Olaparib + RT | 300 | 7 | 7 | 6 | 3 | 1 | 0 | 01/18/2019 | 190 | 84 | |
| 2 RT | 7 | 7 | 6 | 4 | 2 | 0 | ||||||||
| 14 | 14 | 12 | 7 | 3 | 0 | |||||||||
| Yes | A011106-Breast, Neoadj, ALTERNATE study | 1 | E | Total Registrations | 94 | 20 | 9 | 0 | 0 | 0 | 04/29/2014 | 95 | ||
| 94 | 20 | 9 | 0 | 0 | 0 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 259 | 115 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo | 1 | E | Total Registrations | 74 | 15 | 5 | 1 | 0 | 0 | 10/16/2015 | 171 | |||
| 74 | 15 | 5 | 1 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | E | Total Registrations | 7 | 6 | 1 | 0 | 0 | 0 | 06/22/2018 | 159 | 81 | ||
| 7 | 6 | 1 | 0 | 0 | 0 | |||||||||
| No | A011401-Breast, adj, Stage II/III HER2-, weight loss | 1 | E | Total Registrations | 251 | 81 | 40 | 13 | 4 | 1 | 10/05/2016 | 214 | ||
| 251 | 81 | 40 | 13 | 4 | 1 | |||||||||
| 2 | E | Total Registrations | 231 | 76 | 39 | 12 | 3 | 1 | 10/05/2016 | |||||
| 231 | 76 | 39 | 12 | 3 | 1 | |||||||||
| A011502-Brst, Adj, Nodal+&HER2-, Aspirin vs. Placebo | 1 | E | Total Registrations | 117 | 67 | 39 | 19 | 3 | 1 | 03/20/2017 | 370 | 209 | ||
| 117 | 67 | 39 | 19 | 3 | 1 | |||||||||
| A221405-Breast, ET interruption, Pregnancy Outcomes | 1 | E | Total Registrations | 19 | 7 | 6 | 1 | 0 | 0 | 05/08/2017 | 128 | 53 | ||
| 19 | 7 | 6 | 1 | 0 | 0 | |||||||||
| B51-Breast, Regional Nodal XRT | 1 | E | Total Registrations | 37 | 8 | 4 | 3 | 2 | 0 | 06/13/2014 | 157 | |||
| 37 | 8 | 4 | 3 | 2 | 0 | |||||||||
| EA1131-Brst, TNBC, Post-op Chemo vs Obs | 0 | E | Total Registrations | 32 | 14 | 5 | 2 | 1 | 0 | 11/12/2015 | 126 | |||
| 32 | 14 | 5 | 2 | 1 | 0 | |||||||||
| 1 | E | Total Registrations | 17 | 6 | 3 | 1 | 1 | 0 | 11/12/2015 | |||||
| 17 | 6 | 3 | 1 | 1 | 0 | |||||||||
| EA1151-Brst, Tomosynthesis Mammographic Screening | 1 | E | Total Registrations | 571 | 404 | 252 | 140 | 45 | 8 | 01/30/2018 | 151 | 79 | ||
| 571 | 404 | 252 | 140 | 45 | 8 | |||||||||